November 3, 2017
Via Email and EDGAR
Jeffrey Gabor
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: Jaguar Health, Inc.
Registration Statement on Form S-3
Filed October 20, 2017 and amended November 1, 2017
File No. 333-221041
Ladies and Gentlemen:
Jaguar Health, Inc., a Delaware corporation (the “Registrant”), hereby requests the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) be declared effective by the Securities and Exchange Commission on November 6, 2017, at 4:00 p.m., Eastern Standard Time, or as soon thereafter as is practicable.
Please confirm effectiveness by advising our counsel, Michael S. Lee of Reed Smith LLP, at (212) 549-0358.
Very truly yours,
Jaguar Health, Inc.
|
/s/ Lisa A. Conte |
|
|
|
|
|
Lisa A. Conte |
|
|
Chief Executive Officer and President |
|
Jaguar Health, Inc. · 201 Mission Street, Suite 2375 · San Francisco, CA 94105
Tel: +1 (415) 371-8300 · Fax: +1 (415) 371-8311 · https://jaguar.health